Amanote Research
Register
Sign In
Common Variant in VEGFA and Response to Anti-Vegf Therapy for Neovascular Age-Related Macular Degeneration
Current Molecular Medicine
- United Arab Emirates
doi 10.2174/15665240113139990048
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Medicine
Molecular Medicine
Molecular Biology
Date
June 1, 2013
Authors
L. Zhao
S. Grob
R. Avery
A. Kimura
D. Pieramici
J. Lee
M. Rabena
S. Ortiz
J. Quach
G. Cao
H. Luo
M. Zhang
M. Pei
Y. Song
P. Tornambe
M. Goldbaum
H. Ferreyra
I. Kozak
K. Zhang
Publisher
Bentham Science Publishers Ltd.
Related search
Genetic Biomarkers in the VEGF Pathway Predicting Response to Anti-Vegf Therapy in Age-Related Macular Degeneration
BMJ Open Ophthalmology
Ophthalmology
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
Macular Atrophy in Neovascular Age Related Macular Degeneration
Journal of Clinical Review & Case Reports
Recovery of Photoreceptor Outer Segments After Anti-Vegf Therapy for Age-Related Macular Degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Intravitreal Bevacizumab vs Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration
Archives of Ophthalmology
Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine
Medicine
Clinical Risk Factors for Poor Anatomic Response to Ranibizumab in Neovascular Age-Related Macular Degeneration§
Open Ophthalmology Journal
Ophthalmology
Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
JAMA Ophthalmology
Ophthalmology
